Posts

Transition to Digital Ads for Pharmaceutical Brand Managers

Image
Why “Visual Aid” Thinking May Not Help Pharma Anymore? Relearning the art of basic messaging “ Keep it crisp ” bosses repeatedly told brand managers while making the visual aid. But then, “ this point is important ”, “ that graph is from new study ”, “this is our main line since longtime” kind of remarks from brand managers always paved way to content overload in our humble visual aid making it look like a brochure or a menu card often. Moreover, “visual aids” as we call them often have everything else except a strong visual that was supposed to communicate what it was meant to. Pharma brand managers have habitually built up to a typical way of making visual aids with indications, logo, pneumonic, punchline with some graphs and cure rates. At times, in the name of creativity, we have often have killed the very purpose of basic message by forcing some unwanted gimmicks in the name of concept pages. But seldom made an impact as doctors often say. With digit

Will "LIKE, SHARE & SUBSCRIBE"​ Invade The Pharmaceutical Marketing Post-COVID?

Image
Will "LIKE, SHARE & SUBSCRIBE"​ Invade The Pharmaceutical Marketing Post-COVID? The Toughest Is That First Step. Some may ask, is digital in pharma really needed? Few say YES! Even me because information spread that has been happening all this while has been more through "word of mouth", asserting a perspective, the very purpose we go "digital" is for connectivity and speed. The core reason I am in favor of digitization with “virality” in pharmaceutical marketing is because I relate to the era of "capitalist vs communist" school of thoughts. In the early years of "India Pharma" a few companies manned the market turf with few as competition, where "word of mouth" worked wonders. Today, with many small or medium companies fighting against several small and medium companies, we need width, depth speed & yet need be patient-centric too then digital is an answer.  Many accept that "India Pharma&qu

Covid19 & Pharmaceutical Marketing : The 5Cs for the New Normal

Image
Pharmaceutical Marketing : The 5Cs for the New Normal   Twitter: @pawankulkarni “There are decades where nothing happens, and there are weeks where decades happen” Vladimir Lenin’s line might depict the COVID19 strike. For most of the companies in India, the month of March is a closure of financial year. Nevertheless, no one had expected that this month would bring a closing to many of the routines they practiced since decades. Within a fortnight of lockdown, an unpredictable trend (not only in pharmaceuticals) across industries is accelerated which was not expected nor not known to anyone. With the rapid spread of coronavirus (COVID-19) around the world, we are seeing a lot of uncertainty. Healthcare systems are reaching their limits and have even gone beyond something we have not seen before. The “NEW NORMAL” has hit the entire world and not spared the pharmaceutical industry as well. Covid19 came as malignancy to the marketers’ job and benign to the clim